pilocarpine has been researched along with Cell Transformation, Neoplastic in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pilocarpine is a cholinergic agent that promotes salivation." | 2.80 | Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study. ( Agar, M; Carmont, SA; Currow, D; Good, P; Hardy, J; Mitchell, GK; Nikles, J; Schluter, PJ; Senior, H; Vora, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikles, J | 1 |
| Mitchell, GK | 1 |
| Hardy, J | 1 |
| Agar, M | 1 |
| Senior, H | 1 |
| Carmont, SA | 1 |
| Schluter, PJ | 1 |
| Good, P | 1 |
| Vora, R | 1 |
| Currow, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Pilocarpine in Patients With Xerostomia[NCT02982577] | Phase 4 | 80 participants (Anticipated) | Interventional | 2016-04-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pilocarpine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study.
Topics: Administration, Buccal; Cell Transformation, Neoplastic; Cholinergic Agents; Cross-Over Studies; Fea | 2015 |